• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚洲人群中肠道微生物群、代谢产物和细胞因子与前列腺癌风险的关系。

Gut microbiota, metabolites, and cytokines in relation to the risk of prostate cancer in the Asian population.

作者信息

Wang Zhengshi, Chen Haotian, Liu Yongqiang, Zou Libin, Zhang Zhijin, Yin Zhiqiang, Mao Shiyu, Guo Changcheng, Yang Bin, Wu Pengfei, Yao Xudong

机构信息

Department of Urology, Shanghai Tenth People's Hospital, Clinical Medical College of Nanjing Medical University, Shanghai, China.

Department of Urology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.

出版信息

Front Oncol. 2025 Jan 15;14:1466190. doi: 10.3389/fonc.2024.1466190. eCollection 2024.

DOI:10.3389/fonc.2024.1466190
PMID:39882449
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11774728/
Abstract

PURPOSE

Studies have shown that gut microbiota is involved in the tumorigenesis and development of prostate cancer. We aimed to perform a comprehensive analysis of causal associations of gut microbiota, metabolites, and cytokines with prostate cancer in the Asian population.

PATIENTS AND METHODS

Genome-wide association study (GWAS) summary datasets were collected from the public databases. There were 418 bacterial traits, 452 metabolites, 91 cytokines, 5408 cases of prostate cancer from East Asia, and 109,347 controls included. Mendelian randomization (MR) analyses were performed to investigate their causal relationships. Sensitivity analyses were conducted to test the reliability of MR results. Furthermore, the FinnGen database was used to assess the generalizability of our findings based on Asians.

RESULTS

There were a total of 17 bacterial traits, 28 metabolites (including 2 microbiota-associated metabolites), and 9 cytokines to be significantly associated with prostate cancer in Asians (P < 0.05). Further MR analyses of these positive results indicated that /TNFSF10 axis, /TNFRSF14 axis, /TNFSF10 axis, and P_Proteobacteria/cholesterol axis were key signaling pathways involved in the progression of prostate cancer. Notably, /TNFSF10 axis and /TNFRSF14 axis were found to act as protective factors, while the other two signaling axes played a crucial role in promoting the progression of prostate cancer. Sensitivity analyses further confirmed the reliability of our findings. Using the European population as outcome, we further assessed the generalizability of our conclusions and found limited applicability to Europeans.

CONCLUSIONS

We found that there were causal associations of gut microbiota, metabolites, and cytokines with prostate cancer in Asians. The causal effects of gut microbiota on prostate cancer were partially mediated by metabolites and cytokines. These findings might contribute to the development of new therapeutic strategies for prostate cancer.

摘要

目的

研究表明肠道微生物群参与前列腺癌的发生和发展。我们旨在对亚洲人群中肠道微生物群、代谢物和细胞因子与前列腺癌的因果关联进行全面分析。

患者和方法

从公共数据库收集全基因组关联研究(GWAS)汇总数据集。纳入了418个细菌特征、452种代谢物、91种细胞因子、来自东亚的5408例前列腺癌病例以及109347名对照。进行孟德尔随机化(MR)分析以研究它们之间的因果关系。进行敏感性分析以检验MR结果的可靠性。此外,使用芬兰基因组数据库(FinnGen database)基于亚洲人评估我们研究结果的普遍性。

结果

在亚洲人中,共有17个细菌特征、28种代谢物(包括2种与微生物群相关的代谢物)和9种细胞因子与前列腺癌显著相关(P < 0.05)。对这些阳性结果进一步进行MR分析表明,/TNFSF10轴、/TNFRSF14轴、/TNFSF10轴和P_变形菌门/胆固醇轴是参与前列腺癌进展的关键信号通路。值得注意的是,/TNFSF10轴和/TNFRSF14轴被发现起到保护作用,而其他两个信号轴在促进前列腺癌进展中起关键作用。敏感性分析进一步证实了我们研究结果的可靠性。以欧洲人群作为结果,我们进一步评估了我们结论的普遍性,发现对欧洲人的适用性有限。

结论

我们发现在亚洲人中肠道微生物群、代谢物和细胞因子与前列腺癌存在因果关联。肠道微生物群对前列腺癌的因果效应部分由代谢物和细胞因子介导。这些发现可能有助于开发前列腺癌的新治疗策略。

相似文献

1
Gut microbiota, metabolites, and cytokines in relation to the risk of prostate cancer in the Asian population.亚洲人群中肠道微生物群、代谢产物和细胞因子与前列腺癌风险的关系。
Front Oncol. 2025 Jan 15;14:1466190. doi: 10.3389/fonc.2024.1466190. eCollection 2024.
2
Inflammatory cytokines mediate the gut microbiota-EGPA subtype link: a Mendelian randomization study.炎症细胞因子介导肠道微生物群与嗜酸性粒细胞肉芽肿性多血管炎(EGPA)亚型的关联:一项孟德尔随机化研究
Clin Rheumatol. 2025 Jun 12. doi: 10.1007/s10067-025-07526-5.
3
Gut microbiota causally affects ulcerative colitis by potential mediation of plasma metabolites: A Mendelian randomization study.肠道微生物群通过血浆代谢物的潜在介导作用对溃疡性结肠炎产生因果影响:一项孟德尔随机化研究。
Medicine (Baltimore). 2025 Jun 27;104(26):e42791. doi: 10.1097/MD.0000000000042791.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Causality of genetically determined gut microbiota on lung cancer: a Mendelian randomization study.基因决定的肠道微生物群与肺癌的因果关系:一项孟德尔随机化研究。
J Thorac Dis. 2025 Jun 30;17(6):4062-4078. doi: 10.21037/jtd-24-1796. Epub 2025 Jun 26.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
Exploring the role of gut microbiota in intervertebral disc degeneration: insights from bidirectional Mendelian randomization analysis.探索肠道微生物群在椎间盘退变中的作用:双向孟德尔随机化分析的见解
Eur Spine J. 2025 Apr 21. doi: 10.1007/s00586-025-08794-0.
10
Selenium for preventing cancer.硒预防癌症。
Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4.

本文引用的文献

1
-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis.衍生代谢物通过调节 IDO1/Kyn/AHR 轴抑制调节性 T 细胞来增强结直肠癌的抗 PD-1 疗效。
Gut. 2023 Nov 24;72(12):2272-2285. doi: 10.1136/gutjnl-2023-329543.
2
Causal associations between gut microbiota and urological tumors: a two-sample mendelian randomization study.肠道微生物群与泌尿系统肿瘤之间的因果关系:一项两样本孟德尔随机化研究。
BMC Cancer. 2023 Sep 11;23(1):854. doi: 10.1186/s12885-023-11383-3.
3
The Association between the Gut Microbiome and Development and Progression of Cancer Treatment Adverse Effects.
肠道微生物群与癌症治疗不良反应的发生和进展之间的关联。
Cancers (Basel). 2023 Aug 28;15(17):4301. doi: 10.3390/cancers15174301.
4
Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.循环炎症蛋白的遗传学鉴定出了免疫介导疾病风险的驱动因素和治疗靶点。
Nat Immunol. 2023 Sep;24(9):1540-1551. doi: 10.1038/s41590-023-01588-w. Epub 2023 Aug 10.
5
Potential effects of gut microbiota on host cancers: focus on immunity, DNA damage, cellular pathways, and anticancer therapy.肠道微生物群对宿主癌症的潜在影响:关注免疫、DNA 损伤、细胞途径和抗癌治疗。
ISME J. 2023 Oct;17(10):1535-1551. doi: 10.1038/s41396-023-01483-0. Epub 2023 Aug 8.
6
ESR2 polymorphisms on prostate cancer risk: A systematic review and meta-analysis.ESR2 多态性与前列腺癌风险:系统评价和荟萃分析。
Medicine (Baltimore). 2023 Jun 9;102(23):e33937. doi: 10.1097/MD.0000000000033937.
7
Gut microbiota dysbiosis promotes the development of epithelial ovarian cancer regulating Hedgehog signaling pathway.肠道微生物失调通过调节 Hedgehog 信号通路促进上皮性卵巢癌的发展。
Gut Microbes. 2023 Jan-Dec;15(1):2221093. doi: 10.1080/19490976.2023.2221093.
8
Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors.抗 HVEM mAb 治疗在体外和体内均改善抗肿瘤免疫,在表达人类 HVEM 和 BTLA 分子的新型转基因小鼠模型中,该模型受到表达 HVEM 的肿瘤的挑战。
J Immunother Cancer. 2023 May;11(5). doi: 10.1136/jitc-2022-006348.
9
Gut microbiota and risk of five common cancers: A univariable and multivariable Mendelian randomization study.肠道微生物群与五种常见癌症的风险:单变量和多变量孟德尔随机化研究。
Cancer Med. 2023 May;12(9):10393-10405. doi: 10.1002/cam4.5772. Epub 2023 Mar 7.
10
Leucine zipper protein 2 serves as a prognostic biomarker for prostate cancer correlating with immune infiltration and epigenetic regulation.亮氨酸拉链蛋白2作为前列腺癌的预后生物标志物,与免疫浸润和表观遗传调控相关。
Heliyon. 2022 Sep 29;8(10):e10750. doi: 10.1016/j.heliyon.2022.e10750. eCollection 2022 Oct.